Potent, persistent induction and modulation of cellular immune responses in rhesus macaques primed with Ad5hr-simian immunodeficiency virus (SIV) env/rev, gag, and/or nef vaccines and boosted with SIV gp120. - Test2 - elhamkhani - TriplyDB

Potent, persistent induction and modulation of cellular immune responses in rhesus macaques primed with Ad5hr-simian immunodeficiency virus (SIV) env/rev, gag, and/or nef vaccines and boosted with SIV gp120.

Potent, persistent induction and modulation of cellular immune responses in rhesus macaques primed with Ad5hr-simian immunodeficiency virus (SIV) env/rev, gag, and/or nef vaccines and boosted with SIV gp120.

http://www.wikidata.org/entity/Q35182076

about

Human immunodeficiency virus vaccine an update.Construction and immunogenicity of replication-competent adenovirus 5 host range mutant recombinants expressing HIV-1 gp160 of SF162 and TV1 strains.Replicating rather than nonreplicating adenovirus-human immunodeficiency virus recombinant vaccines are better at eliciting potent cellular immunity and priming high-titer antibodies.Immune responses in macaques to a prototype recombinant adenovirus live oral human papillomavirus 16 vaccine.Rapid SIV Env-specific mucosal and serum antibody induction augments cellular immunity in protecting immunized, elite-controller macaques against high dose heterologous SIV challenge.Combining viral vectored and protein-in-adjuvant vaccines against the blood-stage malaria antigen AMA1: report on a phase 1a clinical trial.HIV-1 CD4-induced (CD4i) gp120 epitope vaccines promote B and T-cell responses that contribute to reduced viral loads in rhesus macaques Ability of herpes simplex virus vectors to boost immune responses to DNA vectors and to protect against challenge by simian immunodeficiency virus A replication-competent adenovirus-human immunodeficiency virus (Ad-HIV) tat and Ad-HIV env priming/Tat and envelope protein boosting regimen elicits enhanced protective efficacy against simian/human immunodeficiency virus SHIV89.6P challenge in rhe Low-dose penile SIVmac251 exposure of rhesus macaques infected with adenovirus type 5 (Ad5) and then immunized with a replication-defective Ad5-based SIV gag/pol/nef vaccine recapitulates the results of the phase IIb step trial of a similar HIV-1 va A call for replicating vector prime-protein boost strategies in HIV vaccine design.Replicating adenovirus-simian immunodeficiency virus (SIV) vectors efficiently prime SIV-specific systemic and mucosal immune responses by targeting myeloid dendritic cells and persisting in rectal macrophages, regardless of immunization route.Replicating and non-replicating viral vectors for vaccine development Antibodies to gp120 and PD-1 expression on virus-specific CD8+ T cells in protection from simian AIDS Sequential priming with simian immunodeficiency virus (SIV) DNA vaccines, with or without encoded cytokines, and a replicating adenovirus-SIV recombinant followed by protein boosting does not control a pathogenic SIVmac251 mucosal challenge Protection against mucosal simian immunodeficiency virus SIV(mac251) challenge by using replicating adenovirus-SIV multigene vaccine priming and subunit boosting.Comparative study of Tat vaccine regimens in Mauritian cynomolgus and Indian rhesus macaques: influence of Mauritian MHC haplotypes on susceptibility/resistance to SHIV(89.6P) infection.Correlation of vaccine-elicited systemic and mucosal nonneutralizing antibody activities with reduced acute viremia following intrarectal simian immunodeficiency virus SIVmac251 challenge of rhesus macaques.Impact of antibody quality and anamnestic response on viremia control post-challenge in a combined Tat/Env vaccine regimen in rhesus macaques.Systemic neutralizing antibodies induced by long interval mucosally primed systemically boosted immunization correlate with protection from mucosal SHIV challenge.Contribution of nonneutralizing vaccine-elicited antibody activities to improved protective efficacy in rhesus macaques immunized with Tat/Env compared with multigenic vaccines.Chlamydial Type III Secretion System Needle Protein Induces Protective Immunity against Chlamydia muridarum Intravaginal Infection.Recent advances in antibody-inducing poxviral and adenoviral vectored vaccine delivery platforms for difficult disease targets.Immune response in rhesus macaques after mixed modality immunisations with DNA, recombinant adenovirus and recombinant gp120 from human immunodeficiency virus type 1.Therapeutic conserved elements (CE) DNA vaccine induces strong T-cell responses against highly conserved viral sequences during simian-human immunodeficiency virus infection.Modified Newcastle Disease virus as an improved vaccine vector against Simian Immunodeficiency virus.Replicating adenovirus vector prime/protein boost strategies for HIV vaccine development

P2860

Q30432382-D9FFE037-90E9-444F-9B9E-AF1E37FF61C2 Q33872445-81631B8C-F6D0-4E7D-93F6-127DDA7FE6EC Q33911986-904FB935-C6EB-4B50-B4CE-CC0C66C0D903 Q34260720-03C3FE74-AA27-4172-8164-B895F688E55C Q34574409-757ECF43-2BF2-438C-B1BD-9B294FA77995 Q34600955-73BE5B5A-0636-4666-8271-25856B4FC578 Q35032794-EBF92828-9C8D-4B1F-90B6-4154627133EC Q35675044-77BBF7E8-D80A-42E3-B1C0-80B36B207D7F Q35785031-B875403D-E5A6-4406-90C6-2EC6389D5B92 Q35826525-7DDB6849-5C4B-478C-BB8A-ABF6EEF34E40 Q35851801-1C6BC17C-9518-48D5-A1AF-FBA55B0112D5 Q35940685-9CF21E60-465F-47D8-9285-B7D9B4959A2B Q36464587-CDF9CA1E-33AE-425A-8A05-58C9991E0A44 Q36667821-D99B84CE-C409-4233-8D2E-58697F01C858 Q36949703-2A91B063-8A78-4CEA-85F9-00774EB120CC Q36954239-FEE8A644-8BED-4C64-AEEA-EC41D964315E Q36961218-38D1B2FE-1BBB-496D-9852-DEE83790DA92 Q37033311-66021224-21EB-40A4-B458-29D8DFCD6E26 Q37096865-00240DA5-B826-4C1F-B8BA-7A7680911A41 Q37297052-B698FF68-51E9-4A33-9717-96C8A45EAE03 Q37347813-94A3A77A-1B37-46BF-B70D-4422376D1BC0 Q37742680-28081A2E-D8C0-4FF1-A3C0-F95AC6013C38 Q38096489-FC242F38-945D-4B5F-8C83-80003602212C Q45411816-3EDB2BAE-D5AA-447F-8849-BEE804550836 Q52592228-E786601A-530D-49A4-A131-D22A26F91496 Q55237722-71AFB0A2-CBBB-4D8E-9F70-6CBF24B462DF Q56993265-72CC1408-0331-4D0B-9967-47D1F0D3F9EB

P2860

Potent, persistent induction and modulation of cellular immune responses in rhesus macaques primed with Ad5hr-simian immunodeficiency virus (SIV) env/rev, gag, and/or nef vaccines and boosted with SIV gp120.

http://www.wikidata.org/entity/Q35182076

description

2003 nî lūn-bûn

@nan

2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Potent, persistent induction a ...... es and boosted with SIV gp120.

@ast

Potent, persistent induction a ...... es and boosted with SIV gp120.

@en

type

label

Potent, persistent induction a ...... es and boosted with SIV gp120.

@ast

Potent, persistent induction a ...... es and boosted with SIV gp120.

@en

prefLabel

Potent, persistent induction a ...... es and boosted with SIV gp120.

@ast

Potent, persistent induction a ...... es and boosted with SIV gp120.

@en

P1433

Q35182076-AB4B9C11-F049-4FEE-8A33-8796C46326F0

P1476

Q35182076-B18ED8C8-6F15-4E75-BB01-898F2138C640

P2093

Q35182076-092AF3BB-5007-4EBB-8F42-0FDA089AF87B

Q35182076-486B0338-DC13-4136-A7EB-2FD6B93DE1A8

Q35182076-551F1B2E-A616-4172-A589-6555341540A6

Q35182076-6F9A676A-3CAA-45D6-8ED8-8CEECB77D517

Q35182076-75228B27-64F2-44F8-B93D-3C324DA21C79

Q35182076-89A7C203-B06C-4EA1-8F9D-5A2E1D641692

Q35182076-A59D20F5-B93A-437C-825E-052575A180FD

Q35182076-A823284D-85B9-4E10-9735-D993DFE29310

Q35182076-A8342909-8032-45F0-BDE2-9CF509DC3B1E

Q35182076-BB35EF6A-B1DA-4EA8-B79B-F10B8086585E

P2860

Q35182076-01E74C6F-73BC-49EF-AA1C-A3E91D574FEB

Q35182076-057044DB-4360-4511-A51E-F823CBE37E64

Q35182076-094EDA7F-4311-472A-9204-34A72B386178

Q35182076-0DF8D3DA-6EF9-4065-9687-A4ED210B05F4

Q35182076-0F2A5956-6D7C-4615-A97B-F262875A2082

Q35182076-1191BC29-0164-4C9C-B0E8-F64A6ACC8C06

Q35182076-13997828-7836-4059-A4AD-ABEA473DD0A5

Q35182076-13B4280A-131C-4F95-8205-22E458D06242

Q35182076-19C9A454-C58F-4019-AFDB-986679FD5B72

Q35182076-1AC18C41-4619-4205-A909-A25329BF4483

P304

Q35182076-F84A3E95-DBEA-4F37-923B-E07328B83AFE

P31

Q35182076-59689A8F-FFAF-487C-A228-734A89FF152E

P356

Q35182076-A08EE213-6E2E-4DE3-8AFD-3E7A5A034BD0

P407

Q35182076-C7F5AF14-0669-4D14-9C4B-5CC764C41720

P433

Q35182076-96E6A393-B680-4F52-9E3F-2E773CEA771F

P478

Q35182076-0174ACD1-30AC-4616-B215-A48E36437F90

P577

Q35182076-8AD06E70-6592-4FDB-B5B1-C86650E3255A

P5875

Q35182076-9932AA95-6649-4CF6-8A1F-E8A68A79AA75

P698

Q35182076-D239EA37-CCCA-4E68-A105-50EB50C771A7

P921

Q35182076-1686AC15-2783-44B1-A1D2-8781271A8530

P932

Q35182076-93E78FC4-B5AD-4EB7-8D3F-D24BF50CF5CE

P356

JVI.77.16.8607-8620.2003

P1433

Journal of Virology

P1476

Potent, persistent induction a ...... es and boosted with SIV gp120.

@en

P2093

Bo Peng

http://www.w3.org/2001/XMLSchema#string

Cindy Munch

http://www.w3.org/2001/XMLSchema#string

David Venzon

http://www.w3.org/2001/XMLSchema#string

Ersell Richardson

http://www.w3.org/2001/XMLSchema#string

George N Pavlakis

http://www.w3.org/2001/XMLSchema#string

Joel Pinczewski

http://www.w3.org/2001/XMLSchema#string

Kristine Aldrich

http://www.w3.org/2001/XMLSchema#string

L Jean Patterson

http://www.w3.org/2001/XMLSchema#string

Marjorie Robert-Guroff

http://www.w3.org/2001/XMLSchema#string

Melissa Leonard

http://www.w3.org/2001/XMLSchema#string

P2860

Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection

Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome

Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia

Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies

Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes

Importance of the nef gene for maintenance of high virus loads and for development of AIDS

The conserved core of human immunodeficiency virus type 1 Nef is essential for association with Lck and for enhanced viral replication in T-lymphocytes.

Boosting of SIV-specific immune responses in rhesus macaques by repeated administration of Ad5hr-SIVenv/rev and Ad5hr-SIVgag recombinants.

Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene.

Protection of Macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies.

P304

8607-8620

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.77.16.8607-8620.2003

http://www.w3.org/2001/XMLSchema#string

P407

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

77

http://www.w3.org/2001/XMLSchema#string

P577

2003-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10640174

http://www.w3.org/2001/XMLSchema#string

P698

12885879

http://www.w3.org/2001/XMLSchema#string

P921

Simian immunodeficiency virus

P932

167211

http://www.w3.org/2001/XMLSchema#string